Success of Iui in adenomyotic uterus after three months of letrozole therapy with previous unsuccessful Iui- a pilot study

Effect of letrozoole therapy in unsuccessful iui in adenomyosis uterus- a pilot study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/074166

Enrollment

Registered

2024-09-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N97- Female infertility

Interventions

Intervention1: To study the effect of letrozole therapy for 3 months in cases of unsuccessful IUI with adenomyosis: Ethical clearance will be obtained from the institutional ethics committee of UCMS a

Eligibility

Inclusion criteria

Inclusion criteria: To study the effect of letrozole therapy for 3 months in cases of unsuccessful IUI with adenomyosis

Exclusion criteria

Exclusion criteria: 1. To compare USG changes in study subjects before and after 3 months of letrozole therapy 2. To compare dysmenorrhea using visual analogue score and menstrual blood flow using pictoral blood assessment chart at 6 and 12 weeks of letrozole therapy 3. To observe side effects of letrozole therapy if any like nausea, vomiting and ovarian cyst, if any other will observe

Design outcomes

Primary

Measure	Time frame
To study the effect of letrozole therapy for 3 months in cases of unsuccessful IUI with adenomyosisTimepoint: 3 months	—

Secondary

Measure	Time frame
1. To compare USG changes in study subjects before and after 3 months of letrozole therapy 2. To compare dysmenorrhea using visual analogue score and menstrual blood flow using pictoral blood assessment chart at 6 and 12 weeks of letrozole therapy 3. To observe side effects of letrozole therapy if any like nausea, vomiting and ovarian cyst, if any other will observe Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Medha Majumder

University College of medical Sciences

dralpanasingh@gmail.com7042109290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026